Evidence check: DNA Stoffwechseltest in the context of Langlebigkeit

DNA metabolism tests, such as those offered by MyBody-X, analyze genetic variants linked to energy metabolism – e.g., rs17782313 (MC4R, BMI), TCF7L2 (diabetes risk), or APOC3 (triglycerides). The provided context shows that these variants are associated with moderate effects in GWAS studies (e.g., OR ~1.2–1.4 for BMI or diabetes). However, there is no direct evidence in the context linking these to longevity. Longevity is a multifactorial trait influenced by lifestyle, environment, epigenetics, and hundreds of genes with tiny individual effects. A single test on a few SNPs cannot reliably predict life expectancy. The evidence is mixed: solid GWAS data exist for metabolic traits, but extrapolation to longevity is speculative. Moreover, many such tests lack clinical validation and are subject to marketing hype. A positive finding should be seen as a prompt for a healthy lifestyle, not a verdict. For credible longevity assessment, comprehensive approaches (blood biomarkers, family history, medical guidance) are required.